Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections in Tlaxcala, Mexico

被引:0
作者
Meneses-Leon, Joacim [1 ]
Hernandez-Lopez, Rubi [2 ]
Hernandez-Salazar, Sonia [1 ]
Torres-Ibarra, Leticia [3 ]
Rivera-Paredez, Berenice [1 ]
Leon-Maldonado, Leith [3 ]
Magis-Rodriguez, Carlos [4 ]
Lazcano-Ponce, Eduardo [5 ]
Salmeron, Jorge [1 ]
机构
[1] Univ Nacl Autonoma Mexico, Fac Med, Ctr Invest Polit Poblac & Salud, Ciudad De Mexico, Mexico
[2] Banco Mexico, Gerenciade Adm Plan Salud, Oficina Anal Plan Salud, Subgerencia Tecn Plan Salud, Ciudad De Mexico, Mexico
[3] Inst Nacl Salud Publ, Ctr Invest Salud Poblac, Cuernavaca, Mexico
[4] Univ Nacl Autonoma Mexico, Fac Med, Dept Salud Publ, Ciudad De Mexico, Mexico
[5] Inst Nacl Salud Publ, Direcc Gen, Cuernavaca, Morelos, Mexico
关键词
Chlamydia trachomatis; Mexico; Neisseria gonorrhoeae; prevalence; women;
D O I
10.1017/S0950268823001899
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) are widely recognised as two prevalent sexually transmitted infections that can have detrimental effects on women's reproductive health. Previous research has concentrated on studying high-risk populations, resulting in limited epidemiological data regarding the general population. Therefore, the objective of this study was to estimate the prevalence of CT and NG among women attending public primary health care in Tlaxcala, Mexico. The study sample included 2,396 women already participating in the cervical cancer screening programme, from July to November 2014. After obtaining informed consent, the CT and NG tests were conducted on cervical samples, using a nucleic acid amplification test. We estimate the prevalence with 95% confidence intervals (CIs). Women who tested positive were promptly notified and provided with appropriate treatment. In our study population, CT and NG prevalences were 3.2 (95% CI: 2.6-4.0) and 0.01 (95% CI: 0.01-0.03), respectively. CT prevalence was higher in younger women (age < 40), although the results indicate a low prevalence; due to the potentially significant impact of CT and NG on women's health, we require adequate surveillance, and guaranteeing rapid referral to the correct treatment is a priority for the control of these diseases.
引用
收藏
页数:3
相关论文
共 10 条
[1]  
[Anonymous], SEXUALLY TRANSMITTED
[2]   Chlamydia trachomatis infection in users of two family planning clinics [J].
Cetina, TCD ;
Polanco-Reyes, L ;
Fernández-González, V ;
Ruiz-García, S .
SALUD PUBLICA DE MEXICO, 2003, 45 (05) :S657-S661
[3]  
Dorantes H., 2011, ENFERM INFEC MICR CL, V31, P46
[4]   Controversies and evidence on Chlamydia testing and treatment in asymptomatic women and men who have sex with men: a narrative review [J].
Dukers-Muijrers, Nicole H. T. M. ;
Evers, Ymke J. ;
Hoebe, Christian J. P. A. ;
Wolffs, Petra F. G. ;
de Vries, Henry J. C. ;
Hoenderboom, Bernice ;
van der Sande, Marianne A. B. ;
Heijne, Janneke ;
Klausner, Jeffrey D. ;
Hocking, Jane S. ;
van Bergen, Jan .
BMC INFECTIOUS DISEASES, 2022, 22 (01)
[5]   Prevalence of sexually transmitted pathogens associated with HPV infection in cervical samples in a Mexican population [J].
Magana-Contreras, Mariana ;
Contreras-Paredes, Adriana ;
Chavez-Blanco, Alma ;
Lizano, Marcela ;
De la Cruz-Hernandez, Yanira ;
De la Cruz-Hernandez, Erick .
JOURNAL OF MEDICAL VIROLOGY, 2015, 87 (12) :2098-2105
[6]   Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting [J].
Newman, Lori ;
Rowley, Jane ;
Vander Hoorn, Stephen ;
Wijesooriya, Nalinka Saman ;
Unemo, Magnus ;
Low, Nicola ;
Stevens, Gretchen ;
Gottlieb, Sami ;
Kiarie, James ;
Temmerman, Marleen .
PLOS ONE, 2015, 10 (12)
[7]  
Papp JR, 2014, MMWR RECOMM REP, V63, P1
[8]   Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection [J].
Scholes, D ;
Stergachis, A ;
Heidrich, FE ;
Andrilla, H ;
Holmes, KK ;
Stamm, WE .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (21) :1362-1366
[9]   Triage strategies in cervical cancer detection in Mexico: methods of the FRIDA Study [J].
Torres-Ibarra, Leticia ;
Lazcano-Ponce, Eduardo ;
Franco, Eduardo L. ;
Cuzick, Jack ;
Hernandez-Avila, Mauricio ;
Lorincz, Attila ;
Rivera, Berenice ;
Ramirez, Paula ;
Mendiola-Pastrana, Indira ;
Rudolph, Samantha E. ;
Leon-Maldonado, Leith ;
Hernandez, Rubi ;
Barrios, Elizabeth ;
Gravitt, Patti ;
Moscicki, Anna Barbara ;
Schmeler, Kathleen M. ;
Flores, Yvonne N. ;
Mendez-Hernandez, Pablo ;
Salmeron, Jorge .
SALUD PUBLICA DE MEXICO, 2016, 58 (02) :197-210
[10]  
Van der Pol B, 2013, EXPERT REV MOL DIAGN, V13, P131, DOI [10.1586/erm.12.141, 10.1586/ERM.12.141]